Skip to content

Clinical effect of TECAR therapy combined with fascia manipulation on chronic low back pain

Clinical effect of TECAR therapy combined with fascia manipulation on chronic low back pain

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072003
Enrollment
Unknown
Registered
2023-05-31
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic low back pain

Interventions

Fascial manipulation group:Fascia manipulation, each treatment lasting 30 minutes, twice a week, a total of 4 weeks.
First TECAR therapy group:TECAR therapy lasted for 15 minutes, followed by fascia manipulation for 30 minutes, each treatment lasted for 45 minutes, twice a week, for 4 weeks.
TECAR fascia simultaneous therapy:TECAR therapy and fascia manipulation were performed at the same time, and each treatment lasted for 30 minutes, twice a week for 4 weeks.

Sponsors

Sichuan Jinxin Xinan Women & Children Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: ? The duration of waist pain is greater than 12 weeks ? Persistent or intermittent pain in the twelfth thoracic vertebra, between the twelfth costal margin and the transverse crease of hip, with repeated attack or chronic; ? No history of spine and lower limb surgery and trauma; ? There is no contraindication for exercise test (such as severe hypertension, heart disease, peripheral vascular disease, respiratory system disease, etc.)

Exclusion criteria

Exclusion criteria: ? There is pain in the buttocks and thighs of the body; Lower extremity sensory and reflex abnormalities; ? Medications were taken during the experiment; ? Patients caused by specific pathological factors, such as tumor, osteoporosis, lumbar fracture, rheumatic arthritis, lumbar disc herniation with nerve root involvement, and lumbar spondylolisthesis; ? Complicated with severe primary diseases of liver, kidney, hematopoietic system, endocrine system, etc.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale/Score,VAS;the oswestry disability index,ODI;

Countries

China

Contacts

Public ContactBiru Yang

Sichuan Jinxin Xinan Women & Children Hospital

Biru.Yang@hotmail.com+86 159 2521 2755

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026